Clinical Trial Update: Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis [Phase 1, Phase 2]

View source ↗

Summary

This entry reports a Phase 1/2 clinical trial evaluating PIK-HER2 cell immunotherapy for advanced gastric cancer with liver metastasis, led by Second Military M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Liver Metastasis

Drugs mentioned

• PIK-HER2 cells

Snippet

Sponsor: Second Military Medical University | Conditions: Liver Metastasis, Gastric Cancer | Phase 1, Phase 2 | Status: UNKNOWN